R, W., K, S., NP, I., B, O., B, S., N, S., . . . K, R. (2023). 99m Technetium-pyrophosphate bone scan: A potential biomarker for the burden of transthyretin amyloidosis in skeletal muscle: A preliminary study. Muscle & nerve, 67(2), 111. https://doi.org/10.1002/mus.27740
Chicago Style (17th ed.) CitationR, Wlodarski, Seibert K, Issa NP, O'Brien-Penney B, Soliven B, Sarswat N, Appelbaum D, and Rezania K. "99m Technetium-pyrophosphate Bone Scan: A Potential Biomarker for the Burden of Transthyretin Amyloidosis in Skeletal Muscle: A Preliminary Study." Muscle & Nerve 67, no. 2 (2023): 111. https://doi.org/10.1002/mus.27740.
MLA (9th ed.) CitationR, Wlodarski, et al. "99m Technetium-pyrophosphate Bone Scan: A Potential Biomarker for the Burden of Transthyretin Amyloidosis in Skeletal Muscle: A Preliminary Study." Muscle & Nerve, vol. 67, no. 2, 2023, p. 111, https://doi.org/10.1002/mus.27740.